Integra LifeSciences Holdings Corporation (IART)

Market Cap	1.71B
Revenue (ttm)	1.61B
Net Income (ttm)	-6.94M
Shares Out	77.22M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	9.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	384,213
Open	22.54
Previous Close	22.64
Day's Range	21.89 - 22.82
52-Week Range	16.81 - 35.49
Beta	1.23
Analysts	Sell
Price Target	24.67 (+11.23%)
Earnings Date	May 5, 2025

About IART

Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamp...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 16, 1995
• Employees: 4,396
• Stock Exchange: NASDAQ
• Ticker Symbol: IART
• Website: https://www.integralife.com

Analyst Forecast

According to 7 analysts, the average rating for IART stock is "Sell." The 12-month stock price forecast is $24.67, which is an increase of 11.23% from the latest price.

Price Target

$24.67

(11.23% upside)

Analyst Consensus: Sell